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Article focus
  Bone-marrow- (bMSC) and adipose-
derived mesenchymal stem cell (AdMSC) 
osteogenic capacity.
  ovarectomized (ovX)-derived and 
 juvenile-derived mesenchymal stem cell 
characteristics.
  The role of parathyroid hormone (PTH) 
on osteogenic capacity.
Key messages
  bMSCs have a greater osteogenic capac-
ity than AdMSCs.
  Juvenile cells have a greater osteogenic 
and adipogenic differentiative capacity 
than cells derived from ovX cells.
  PTH increases the osteogenic capacity of 
both AdMSCs and bMSCs.
The influence of parathyroid hormone 
1-34 on the osteogenic characteristics 
of adipose- and bone-marrow-derived 
mesenchymal stem cells from juvenile 
and ovarectomized rats
Objectives
Mesenchymal stem cells (Mscs) are of growing interest in terms of bone regeneration. Most 
preclinical trials utilize bone-marrow-derived mesenchymal stem cells (bMscs), although 
this is not without isolation and expansion difficulties. The aim of this study was: to compare 
the characteristics of bMscs and adipose-derived mesenchymal stem cells (AdMscs) from 
juvenile, adult, and ovarectomized (oVX) rats; and to assess the effect of human parathyroid 
hormone (hpTH) 1-34 on their osteogenic potential and migration to stromal cell-derived 
factor-1 (sDF-1).
Methods
cells were isolated from the adipose and bone marrow of juvenile, adult, and previously oVX 
Wistar rats, and were characterized with flow cytometry, proliferation assays, osteogenic 
and adipogenic differentiation, and migration to sDF-1. experiments were repeated with 
and without intermittent hpTH 1-34.
Results
Juvenile and adult Mscs demonstrated significantly increased osteogenic and adipogenic 
differentiation and superior migration towards sDF-1 compared with oVX groups; this was 
the case for AdMscs and bMscs equally. parathyroid hormone (pTH) increased parameters 
of osteogenic differentiation and migration to sDF-1. This was significant for all cell types, 
although it had the most significant effect on cells derived from oVX animals. bMscs from 
all groups showed increased mineralization and migration to sDF-1 compared with AdMscs.
Conclusion
Juvenile Mscs showed significantly greater migration to sDF-1 and significantly greater 
osteogenic and adipogenic differentiation compared with cells from osteopenic rats; this 
was true for bMscs and AdMscs. The addition of pTH increased these characteristics, with 
the most significant effect on cells derived from oVX animals, further illustrating possible 
clinical application of both pTH and Mscs in bone regenerative therapies.
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Strengths and limitations
  A comparison of osteogenic characteristics from two 
viable cell sources.
  Investigation of the underlying genomic changes 
would be beneficial.
introduction
Multiple influences alter the osteogenic capabilities of 
undifferentiated mesenchymal stem cells (MSCs); studies 
have compared the functional differences between cells 
from adolescent and aged animals, as well as the role of 
cell source and osteoporosis on activity.1-4
Postmenopausal oestrogen deficiency leads to an 
uncoupling of the bone remodelling cycle, where upreg-
ulated osteoclast activity is matched only with aberrant 
osteoblast activity, resulting in net resorption.5,6 This is 
characterized by a reduction in bone mass and altered 
trabecular microarchitecture, hence fragility.7
The majority of bone regeneration studies have used 
MSCs derived from bone marrow (bMSCs). This is not 
without problems, including morbidity associated with 
obtaining cells from iliac crest puncture, low cell yield, 
and reduced potency following extensive passage.8 Zuk 
et al9 initially described the use of cells obtained from 
subcutaneous adipose liposuction aspirate as a source 
rich in MSCs (AdMSCs). Moreover, unlike periosteal cells 
or cells obtained from myogenic sources, adipose tissue 
is readily available, harvesting carries very limited mor-
bidity, and cell yield is much greater than that found from 
other sources.10,11 Reports on the osteogenic capacity of 
AdMSCs compared with bMSCs are contradictory; bMSC 
characteristics are thought to be affected by age, unlike 
AdMSCs, where cells are thought to retain all characteris-
tics regardless of the age of the source. Cell yield is also a 
fundamental difference: bMSCs yield 6 × 106 nucleated 
cells per millimetre of aspirate, with a maximum of 0.01% 
being MSCs, while 2 × 106 cells can be isolated from 1 gm 
adipose tissue, 10% of which are stem like.12,13
Studies, including those conducted on postmenopau-
sal women, demonstrate a profound anabolic effect of 
parathyroid hormone 1-34 (PTH).14,15 Moreover, in vitro 
data have shown PTH to mediate MSC fate, increasing not 
only the number of MSCs, but also their preferential 
osteogenic differentiation over adipogenesis.16 Intere-
stingly, these findings have predominantly been reported 
in bMSCs, with very little data on the effect of PTH on 
AdMSCs.
In addition to anabolic effects, PTH has also been 
shown to effect cell mobilization. The stromal cell-derived 
factor-1 (SDF-1)/C-X-C chemokine receptor type 4 
(CXCR4) axis has been found to be an important regula-
tor of stem cell migration. SDF-1, also known as C-X-C 
motif chemokine 12 (CXC1l2), is produced by a multi-
tude of tissue types including fracture endosteum and in 
its active form is bound to the CXCR4 receptor found on 
MSCs. Granero-Moltó et al17 demonstrated dynamic 
stem cell migration to the fracture site in a stabilized tibial 
osteotomy model being CXCR4-dependent. The clinical 
significance of the SDF-1/CXCR4 axis has further been 
alluded to, whereby the overexpression of CXCR4 on 
MSCs led to increases in bone density,18 with increased 
SDF-1 expression following PTH treatment in vitro.19
As such, although comparisons have been made 
between the osteogenic potential of different stem cell 
sources, a very limited body of work compares these dif-
ferences across juvenile, adult, and ovarectomized (ovX) 
animals, nor does this work elucidate their capacity to 
migrate to SDF-1. We completed this study with the pur-
pose of comparing varying sources of MSCs in the pres-
ence of PTH, hypothesizing that MSCs isolated from the 
adipose tissue of ovX rats will have lower osteogenic 
capacity, proliferation, and migration than cells isolated 
from the bone marrow of juvenile counterparts, and that 
coculture with intermittent PTH will upregulate these 
characteristics.
Materials and Methods
Female Wistar rats were used throughout this study. 
Animals were classed as ‘juvenile’ at two to four weeks or 
‘adult’ at six to nine months. one group of animals 
(‘ovX’) were supplied immediately following bilateral 
ovarectomy. These animals were housed for 16 weeks in 
pairs and osteopenia was confirmed by assessing their 
femora, lumbar third and fourth vertebrae, and humeri 
mineral density with peripheral quantitative CT (pQCT) 
compared with age-matched non-ovX controls. A reduc-
tion of 22% in bone mineral density was confirmed; as 
such, our model was one of osteopenia rather than oste-
oporosis. Additionally, ovX animals were aged between 
ten and 13 months at the time of use experimentally.
Bone marrow cell isolation. Following gaseous euthana-
sia, all animals were processed within 60 minutes to main-
tain cell viability. Within a laminar flow hood, dissected 
femora were washed twice with phosphate buffered 
saline (PBS; ThermoFisher, Hemel Hempstead, United 
Kingdom) to remove remaining external debris. Ends 
were transected at the diaphyseal-metaphyseal junction 
leaving a diaphyseal portion that was flushed three times 
with 5 ml of Dulbecco’s Modified Eagle Medium (DMEM, 
ThermoFisher) high glucose, with the aspirate collected 
and cultured in DMEM, 20% foetal calf serum, and 1% 
penicillin-streptomycin (‘standard media’).
Adipose-derived mesenchymal stem cell isolation. AdMSCs 
were isolated from the abdominal subcutaneous fat, 
avoiding perinephric and visceral fat. Under aseptic 
conditions, adipose samples were washed three times 
with PBS following the removal of other soft tissues and 
weighed. Subsequently, specimens were minced with 
sterile scissors; 8 ml of warmed 0.1% collagenase-type II 
(Sigma-Aldrich, Gillingham, United Kingdom) was then 
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added to the adipose tissue and agitated in a 37°C water 
bath for 60 minutes. Samples were centrifuged and the 
supernatant was aspirated and discarded. The pellet was 
resuspended in 5 ml of fresh standard media, and the 
suspension was cultured and used for experimental pro-
cedures at passages 3 to 4.20
All cell work was repeated in triplicate, from the bone 
marrow and adipose tissue of three animals from each 
group (ovX, juvenile, and adult).
Passaged cells were seeded at a density of 4500/cm³ in 
48-well plates (Corning, Ewloe, United Kingdom) and 
cultured in standard media for 24 hours, following which 
media were discarded and the cells were washed with 
PBS to remove nonadherent cells. Culture in standard 
media continued until 80% confluence, after which 
media was supplemented with 1 × 10-⁷ M water-soluble 
dexamethasone (Sigma-Aldrich), 1 × 10-⁴ M ascorbic acid 
(Sigma-Aldrich), and 1 × 10-² M beta-glycerol phosphate 
(Sigma-Aldrich), herein referred to as ‘osteogenic media’.
Alizarin red staining. At days 7, 14, and 21, mineraliza-
tion was assessed by staining calcium deposits with aliza-
rin red. Cells were fixed in formalin and stained with 100 
µl of alizarin red solution. The plates were covered with 
foil and incubated at room temperature for 15 minutes. 
The stain was then aspirated and the cells were washed 
multiple times with PBS until the solution ran clear to 
remove nonspecific staining. Cells were then left in 100 
µl of PBS and images were taken.
To quantify staining, 10% cetylpyridinium chloride 
(CPC) was added to 10 mM of sodium phosphate to 
obtain a working solution of pH 7. Following imaging, 
PBS was discarded from wells and 200 µl of the CPC solu-
tion was added to each well for 15 minutes, agitated at 
room temperature, and covered in foil. Absorbance was 
then read on a plate reader at 570 nm (Tecan Infinite Pro; 
Tecan Trading, Männedorf, Switzerland). A standard 
curve was made by serial dilution of alizarin red working 
solution in CPC and read again at 570 nm. Data were 
normalized for cell numbers, which were quantified 
using DNA Hoechst.
Alkaline phosphatase activity. Alkaline phosphatase (AlP) 
data were collected at days 3, 7, 14, and 21. In total, 50 µl 
of each sample (repeated in duplicate) was combined in a 
96-well Nunc microplate reader with 50 µl of p- Nitrophenol 
phosphate (Sigma-Aldrich) and agitated at 37°C in the dark 
for 30 minutes. Plates were then read at a fluorescence of 
405 nm and measurements expressed in U/l.
For adipogenic characterization, cells were passaged 
and seeded as described for osteogenic differentiation. At 
80% confluence, media was removed and cells were cul-
tured with standard media supplemented with 0.5 mM 
isobultyl-1-methylxanthine, 10 ug/ml insulin, and 0.1 
mM dexamethasone (all Sigma-Aldrich), herein termed 
‘adipogenic media’.
Oil Red O staining. At days 7, 14, and 21, lipid produc-
tion was assessed by staining droplets with oil Red o. For 
fixed cells, 100 ul of 60% isopropanol was added to each 
well and incubated for 15 minutes at room temperature. 
Cells were then washed twice with PBS and incubated in 
oil Red o working solution for 15 minutes at room tem-
perature. After staining, cells were washed carefully with 
60% isopropanol and analyzed. To quantify staining, 200 
ul of 100% isopropanol was added to each well and the 
plate was agitated at room temperature for 15 minutes. 
The supernatant was then collected and absorbance was 
read on a plate reader at wavelength 510 nm.
A standard curve was made by serial dilution of oil 
Red o working solution in isopropanol and read again at 
510 nm.
Cell morphology. Passage 2 and 3 cells from the three 
groups for both sources were cultured in standard media 
and their morphology was assessed by measuring their 
aspect ratio, whereby the ratio of the length of a cell to 
its width was calculated using ImageJ software (National 
Institutes of Health, Bethesda, Maryland).
Characterization of stem cells – flow cytometry. A total 
of 100 000 cells from the bone marrow and adipose of 
juvenile, adult control, and ovX rats were analyzed for 
their cluster differentiation (CD) markers: CD29, 90, 45, 
106, 146, and 34. Cells were labelled with antimouse/
rat CD29-fluorescein (ThermoFisher Scientific, San Diego, 
California), 17 antimouse/rat CD90-allophycocyanin (APC; 
ThermoFisher Scientific), antirat CD45-APC (Thermo-
Fisher Scientific), and CD34-phycoerythrin (PE; Abcam, 
Cambridge, United Kingdom). The CD expression was 
compared with the isotype control. Cells were fixed in 
4% formalin for 15 minutes at room temperature, washed 
with 0.5% bovine serum albumin (BSA), and stained with 
the conjugated primary antibody for one hour at room 
temperature in the dark. After one hour, the cells were 
washed with 0.5% BSA and analyzed on flow cytometer 
(CytoFlEX; Beckman Coulter, Brea, California).
Human parathyroid hormone 1-34 (Teriparatide; 
Bachem, Saint Helens, United Kingdom) was dissolved in 
4 mM hydrochloric acid solution containing 0.1% BSA to 
a stock concentration of 5 mM, which was subsequently 
stored at -20°C. Intermittent regimens involved the cul-
ture of cells in the PTH containing media for six hours in 
every 48-hour cycle at 50 nmol based on a preliminary 
study comparing dosing regimens and concentrations.20 
We repeated the osteogenic differentiation of all groups 
derived from both adipose and bone marrow, with the 
addition of PTH, again assessing with AlP, alizarin red, 
and osteocalcin immunocytochemistry.
The effect of PTH 1-34 on cell proliferation. A total of 
10 000 cells derived from the adipose and bone marrow 
of juvenile, adult, and ovX rats (n = 3 for each group) 
were incubated in DMEM, 20% foetal calf serum, and 1% 
penicillin streptomycin with intermittent PTH. At three, 
seven, ten, and 14 days, 10% Alamar Blue assay (AbD 
Serotec, Kidlington, United Kingdom) was added to the 
culture media for four hours; the resultant media was 
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read at an excitation of 560 nm and an emission of 590 
nm using a Tecan plate reader. The mean absorbance 
was determined from triplicate samples. The absorbance 
was then normalized to DNA assays and a comparison 
was made between groups as per our previous studies.21
The effect of PTH 1-34 on cell migration to SDF-1. At pas-
sage 3, cells were again seeded at a concentration of 
4500 cells/cm² in 48-well plates and cultured with either 
osteogenic media or osteogenic media supplemented 
intermittently with 50 nM of PTH 1-34 for 21 days. A total 
of 10 000 cells from each group were loaded in plain 
DMEM without supplements in the upper compartments 
of a 5 mm pore size Boyden chambers (Corning). The 
lower compartment of the chambers was filled with 100 
ng/ml SDF-1 (Peprotech, london, United Kingdom) in 
standard media, and incubated at 37°C, 5% Co2.
After 16 hours, the cells that migrated to the opposite 
side of the membrane were fixed with 10% formalin and 
stained with Toluidine blue.
Following fixation, the chambers were rested in 200 ul 
of the toluidine solution for three minutes. Subsequently, 
wells were washed three times with distilled water, after 
which wells were analyzed under the microscope, where 
cells that had migrated were counted by selecting six ran-
dom fields at ×20 magnification and calculating the mean 
percentage number of cells. For the control, both the top 
and bottom of the chamber were filled with standard 
media with no SDF-1 and the cells were loaded in the 
upper chamber as described.
Statistical analysis. values are expressed as the mean and 
standard deviation. Data were found to be nonparametric 
following Shapiro–Wilkinson testing, and as such Mann–
Whitney U tests were used for analysis in GraphPad soft-
ware (GraphPad Software, Inc., San Diego, California).
Results
expression of CD markers. There was no significant dif-
ference in CD marker expression by cells obtained from 
any group, regardless of tissue source. Mean CD marker 
expressions (sd 1) are outlined in Table I.
Cell morphology. Both AdMSCs and bMSCs from juvenile 
rats demonstrated a tight spindle-like morphology, with 
no significant difference in mean aspect ratios (bMSC 
18.66, AdMSC 19.1). The mean ratios in adult cells were 
significantly smaller (bMSC 4.99, AdMSC 5.31), although 
again there was no difference between different tissue 
sources. Mesenchymal stem cells from ovX rats had the 
smallest aspect ratio compared with the other cell types 
(bMSC 2.25, AdMSC 1.80).
Proliferation. Although plotted growth curves all showed 
time-dependent growth up to day 14, no significant 
effect on cell metabolic activity or on proliferation when 
normalized against DNA was seen secondary between 
groups. This was despite tissue or age/ovarectomy status 
of the source.
Osteogenic differentiation. Mineralization increased in 
all groups over the 21-day experimental period. At day 
7, juvenile bMSCs produced significantly more calcium 
phosphate than ovX cells (p = 0.038; this trend continued 
over the 21-day period. There was no difference between 
calcium phosphate deposition from juvenile- and adult-
derived bMSCs at any timepoint; this was also the case 
for AdMSCs. Juvenile AdMSCs at all timepoints had signif-
icantly greater mineralization than ovX cells (p = 0.042. 
When comparing tissue source, bMSCs deposited signifi-
cantly more calcium phosphate then AdMSCs; this differ-
ence was most profound for ovX cells (Fig. 1).
on the addition of PTH, cells showed a significant 
increase in alizarin red staining compared with untreated 
groups at all timepoints for bMSCs. This effect was noted 
to be most profound on ovX cells that showed a nearly 
two-fold increase on calcium phosphate deposition com-
pared with untreated cells at day 21 (p = 0.044) (Figs 2a 
and 2b); this effect was also seen in ovX AdMSCs.
bMSCs demonstrated the most significant reaction to 
PTH compared with AdMSCs by day 21 (p = 0.044).
No difference between AlP expression from AdMSCs 
or bMSCs was seen, but as with calcium phosphate dep-
osition, juvenile and adult cells expressed significantly 
more AlP than ovX cells at day 14, when production 
peaked for cells from both tissue sources (p = 0.033). 
Similarly, PTH led to increased AlP production for all cell 
types compared with untreated cells (p = 0.041); this 
affected AdMSCs and bMSCs to the same degree, with no 
difference in the magnitude of the effect independent of 
age or ovarectomy.
Adipogenic. At days 14 and 21, adipocytic differentiation 
was significantly greater in MSCs isolated from juvenile 
animals compared with adult control and ovX groups 
for both tissue sources. MSCs from juvenile rats accu-
mulated significantly greater amounts of lipid from day 
Table i. Mean cluster differentiation (CD) marker expression (sd 1)
CD marker Mean expression, % (sd)
 Adipose Bone marrow
Juvenile  
CD29 95.8 (1.6) 95.1 (2.1)
CD90 91.6 (0.7) 96.6 (3.2)
CD106 86.0 (2.4) 88.0 (2.9)
CD146 90.2 (0.6) 91.0 (8.1)
CD34 2.7 (1.9) 2.6 (7.6)
CD45 9.1 (0.6) 10.9 (8.2)
Adult  
CD29 90.9 (1.6) 91.1 (9.4)
CD90 94.7 (4.9) 97.0 (1.1)
CD106 85.0 (1.6) 85.0 (6.0)
CD146 89.6 (1.2) 89.0 (7.2)
CD34 3.6 (0.5) 3.8 (3.1)
CD45 12.9 (0.7) 9.0 (1.1)
Ovarectomized  
CD29 97.2 (0.6) 99.1 (0.1)
CD90 91.9 (1.4) 94.4 (4.2)
CD106 87.1 (0.6) 87.0 (7.8)
CD146 89.7 (1.9) 90.0 (1.2)
CD34 1.7 (0.8) 1.7 (0.4)
CD45 9.7 (1.2) 11.1 (6)
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7 compared with the other two groups of cells. The rate 
of lipid accumulated from day 7 onwards was greater in 
cells isolated from juvenile rats. Cells isolated from adi-
pose tissue and bone marrow, regardless of donor age or 
whether they were derived from ovX rats, continued to 
show increased lipid formation over the 21-day period, 
although juvenile cells were always more productive 
than those in the adult and ovX groups.
When comparing bMSCs with AdMSCs, there was no 
difference in adipogenic differentiation, but the reduction 
in microdroplet formation was more significant between 
adipose juvenile and ovX cells compared with bMSCs 
(p = 0.037).
Cell migration to SDF-1. In bMSCs, the migration of 
juvenile cells to SDF-1 was significantly greater than for 
ovX- or adult-derived cells (p = 0.046) and was nearly 
twice as high as the migration of ovX cells (p = 0.047). In 
AdMSCs, the migration of MSCs from young rats was sig-
nificantly less than with bMSCs, although the pattern of 
these cells migrating more than cells from ovX animals 
was continued (p = 0.032) (Figs 3 and 4). on the addition 
of PTH, all cell types demonstrated increased migration 
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Graph of alizarin red staining of adipose- and bone-marrow-derived cells. From both sources, juvenile groups demonstrated greater alizarin red staining than 
ovarectomized (ovX) groups (*p < 0.04; †p < 0.05). Bone-marrow-derived juvenile cells showed greater alizarin staining than adipose-derived cells at all time-
points (‡p < 0.03).
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a) Images of calcium phosphate deposition stained with alizarin red from adipose-derived cells. b) Images of calcium phosphate deposition stained with alizarin 
red from bone-marrow-derived cells. PTH, parathyroid hormone; ovX, ovarectomized.
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compared with their untreated counterparts and this 
treatment affected AdMSCs and bMSCs equally.
Discussion
This study examines the capacity of AdMSCs and bMSCs 
to differentiate into adipocytes and osteoblasts, as well as 
the effects of PTH 1-34 dosing regimens on cellular osteo-
genic characteristics and migratory capacity. We found 
that AdMSCs demonstrated poorer calcium phosphate 
deposition, osteocalcin expression, and migration along 
the CXCR4/SDF-1 axis compared with bMSCs, and that 
these differences were more profound for cells derived 
from ovX animals than for their juvenile counterparts. 
We also found differences between cells isolated from 
juvenile and ovX animals for each cell source, with com-
parative reductions in osteogenic and migrative charac-
teristics in ovX-derived cells, although these cells showed 
similar proliferative capacity and CD marker expression 
to juvenile counterparts.
We found no difference in CD marker expression from 
the cells independent of source, age, or ovX status of 
animal. other studies have demonstrated a higher expres-
sion of CD34 from AdMSCs at early culture;11 this CD 
marker is important for cell-to-cell adhesion, as well as 
cell extracellular matrix deposition. Similarly, several 
reports suggest higher CD106 and CD146 from bMSCs. 
our findings were contrary to this, whereby all samples 
were negative for CD34, and there was equal expression 
of CD106 and CD146. This may be explained by the use 
of the cells at passage 3, particularly as previous work has 
demonstrated a reduction in CD34 expression at later 
passage.11 The lack of difference between ovX- and 
juvenile-derived cells and CD markers is in keeping with 
other works,21 although the heterogeneity in study meth-
odologies means only a limited inference can be made 
between the expression of CD markers and the in vivo/in 
vitro activity of cells. Similarly, we found no difference 
morphologically between AdMSCs or bMSCs; both dem-
onstrated the same spindle-like phenotype from juvenile 
populations, and both moved morphologically to a more 
flattened phenotype from aged and ovX animals. 
However, again the value of morphology is limited in 
isolation.
Asumda and Chase22 demonstrated reduced osteo-
genic and adipogenic differentiation ability of bMSCs 
from senile and juvenile rats. However, Singh et al23 
found no observable difference in osteogenic and adipo-
genic differentiation between cells from these groups. 
Similarly, in a rabbit study, Beane et al24 showed no dif-
ference in AlP expression or alizarin red staining between 
bMSCs from juvenile and senile rabbits, but they found 
that age affected the adipogenic differentiation of the 
same cells and also led to reduced adipogenic differentia-
tion in AdMSCs. The reason for the disparate findings 
between the studies is likely to be multifactorial, and may 
be a result of varying culture practices and cell isolation 
techniques. Moreover, we use explanted cells, which 
even at passage 3 are a heterogeneous cell group; 
although they do conform to standard definitions of 
being ‘stem-like’, one wonders if pure or clonal-cultured 
MSCs may demonstrate different characteristics. In addi-
tion, although differences were seldom seen between 
adult and juvenile cells, due to the time taken for osteo-
penia to develop, the ovX animals we used were older 
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than all other groups. As such, differences may be sec-
ondary to their ‘senile’ nature rather than solely 
ovarectomy.
A fundamental advantage of using AdMSCs in bone 
regeneration, rather than bMSCs, is based on the evi-
dence that the proliferative and osteogenic capacity of 
AdMSCs is not affected by age. In the present study, there 
was no difference in proliferation between any MSCs 
independent of age, ovX, or source. This is in contrast 
with other studies assessing bMSCs, whereby MSCs from 
older rats have significantly lower proliferation compared 
with MSCs from young rats.10,25-27 Again, Beane et al24 
looked at MSCs from young and old rabbits derived from 
the bone marrow, muscle, and fat, where the cells from 
bone marrow demonstrated a reduction in proliferation 
with age, whereas cells from the other two sources did 
not. Georgen et al28 found that MSCs from ovX rats had 
a lower proliferation rate than their control counterparts 
and concluded that the low proliferation rate would cor-
relate with reduced self-renewal capacity, which might 
cause a gradual depletion of MSC sources in the bone 
marrow of ovX animals. When comparing the effects of 
intermittent PTH on the osteogenic capacity of AdMSCs 
and bMSCs, we found significant differences. Although 
PTH affected all ovX cells, this change was most signifi-
cant with cells derived from bone marrow, where miner-
alization at day 7 for ovX and young bone marrow cells 
had increased 2.1- and 1.9-fold compared with compara-
tive cells from adipose tissue, which had increased 1.6- 
and 1.5-fold, respectively.
The stimulation, proliferation, and differentiation of 
bone-marrow-derived osteoprogenitor cells by PTH 1-34 
has been well documented in the literature.29 The ana-
bolic window is based on findings of intermittent dosing 
regimens. Contrary to the larger body of literature, we 
did not find an increase in proliferation of cells from any 
group after PTH dosing, although our exposure cycle was 
greater than the documented 30 to 60 minutes that has 
been reported in works as selectively upregulating of the 
cyclic adenosine monophosphate (cAMP)/protein kinase 
A (PKA) pathways.30
We demonstrated that MSCs from ovX rats, whether 
derived from bone marrow or adipose, have a lower in 
vitro migration compared with MSCs from juvenile and 
adult rats. overall, AdMSCs had poorer migrative capac-
ity than those from bone marrow.31,32 SDF-1 is a 
chemokine receptor for CXCR4 and the SDF-1/CXCR4 
biological axis plays an important role in the migration of 
stem cells and the wound repair of tissues and organs. 
The impaired migration capacity of MSCs from rats four 
months after ovariectomy may be due to their low expres-
sion of CXCR4. This could explain the impaired bone for-
mation in osteoporotic patients, as these cells have a 
reduced capacity to migrate to the site of bone loss. 
SDF-1 is produced in the periosteum of injured bone and 
encourages endochondral bone repair by recruiting 
MSCs to the site of injury. Therefore, mobilization of oste-
oblastic progenitors to the bone surface is an important 
step in osteoblast maturation and formation of mineral-
ized tissue. very little work has explored the effect of PTH 
on AdMSCs and their migration; we found that these cells 
also reacted to PTH in a similar way to bMSCs; the per-
centage increase in migration was greatest in ovX cells 
compared with untreated cells.
Interestingly, in vivo studies have yielded mixed results 
on the efficacy of AdMSCs in bone formation. Niemeyer 
et al33 and Hayashi et al34 showed significantly poorer 
fracture healing in sheep and rat defects, respectively, 
compared with the osteogenesis and full bone bridging 
achieved with implanted bMSCs. Indeed, implanted 
undifferentiated AdMSCs tended to differentiate into cells 
with an adipose-like morphology and thus hindered heal-
ing. This is converse to Kang et al35 and Stockmann et al36 
who, in porcine and canine models, respectively, found 
no difference in bone formation with bMSCs and AdMSCs. 
Yet, heterogeneity of subcutaneous versus intra- abdominal 
fat, cell number, cell culture techniques, and fracture 
model makes comparisons between studies difficult, and 
thus renders evaluation of the true potential of AdMSCs 
in vivo difficult.
We found that cell migration and osteogenic differen-
tiation is reduced when derived from osteopenic animals, 
and that bMSCs have greater calcium phosphate deposi-
tion than AdMSCs. Yukata et al37 reported the reduced 
efficacy of PTH on periosteal stem cells in an aged osteo-
penic mouse compared with a juvenile model; con-
versely, our findings demonstrated increased sensitivity 
of ovX cells to PTH. This may have implications for clini-
cal applications. If allogenic cells from younger patients 
are incompatible for use in the aged osteoporotic popu-
lation, then can the addition of PTH improve the ability of 
ovX-derived cells to migrate and differentiate, thus ren-
dering them effective for bone regeneration? Moreover, 
although we demonstrated bMSCs to have superior oste-
ogenic capabilities compared with AdMSCs, in the pres-
ence of PTH 1-34, AdMSCs also showed improved 
mineralization capacities and migration to SDF-1. As 
such, this study also highlights the potential utility of 
AdMSCs when the morbidity associated with bone mar-
row aspiration is too high.
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